|
Name |
Hamisonine
|
| Molecular Formula | C26H32O10 | |
| IUPAC Name* |
7-(2,3-dihydrofuran-4-yl)-18,19-dihydroxy-19-methoxy-1,8,12,17-tetramethyl-3,6,16-trioxapentacyclo[9.9.0.02,4.02,8.012,18]icos-13-ene-5,15,20-trione
|
|
| SMILES |
COC1(O)C(=O)C2(O)C(C)OC(=O)C=CC2(C)C2CCC3(C)C(C4=COCC4)OC(=O)C4OC43C21C
|
|
| InChI |
InChI=1S/C26H32O10/c1-13-24(30)20(29)26(31,32-5)23(4)15(21(24,2)10-7-16(27)34-13)6-9-22(3)17(14-8-11-33-12-14)35-19(28)18-25(22,23)36-18/h7,10,12-13,15,17-18,30-31H,6,8-9,11H2,1-5H3/t13-,15?,17?,18?,21-,22?,23-,24?,25?,26?/m1/s1
|
|
| InChIKey |
MGUZDFKJDHKVOZ-KSWYYIDFSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 504.53 | ALogp: | 0.9 |
| HBD: | 2 | HBA: | 10 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 141.1 | Aromatic Rings: | 6 |
| Heavy Atoms: | 36 | QED Weighted: | 0.322 |
| Caco-2 Permeability: | -5.299 | MDCK Permeability: | 0.00001150 |
| Pgp-inhibitor: | 0.996 | Pgp-substrate: | 0.014 |
| Human Intestinal Absorption (HIA): | 0.04 | 20% Bioavailability (F20%): | 0.971 |
| 30% Bioavailability (F30%): | 0.925 |
| Blood-Brain-Barrier Penetration (BBB): | 0.993 | Plasma Protein Binding (PPB): | 49.09% |
| Volume Distribution (VD): | 1.437 | Fu: | 54.16% |
| CYP1A2-inhibitor: | 0.006 | CYP1A2-substrate: | 0.956 |
| CYP2C19-inhibitor: | 0.049 | CYP2C19-substrate: | 0.748 |
| CYP2C9-inhibitor: | 0.062 | CYP2C9-substrate: | 0.006 |
| CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.067 |
| CYP3A4-inhibitor: | 0.696 | CYP3A4-substrate: | 0.942 |
| Clearance (CL): | 3.633 | Half-life (T1/2): | 0.036 |
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.173 |
| Drug-inuced Liver Injury (DILI): | 0.163 | AMES Toxicity: | 0.827 |
| Rat Oral Acute Toxicity: | 0.982 | Maximum Recommended Daily Dose: | 0.935 |
| Skin Sensitization: | 0.054 | Carcinogencity: | 0.947 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.015 |
| Respiratory Toxicity: | 0.954 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003376 | ![]() |
0.343 | D0I5DS | ![]() |
0.267 | ||
| ENC005317 | ![]() |
0.333 | D0G6AB | ![]() |
0.260 | ||
| ENC005189 | ![]() |
0.333 | D0P0HT | ![]() |
0.259 | ||
| ENC003107 | ![]() |
0.331 | D02JNM | ![]() |
0.259 | ||
| ENC002987 | ![]() |
0.331 | D0IL7L | ![]() |
0.252 | ||
| ENC005188 | ![]() |
0.319 | D0D2TN | ![]() |
0.248 | ||
| ENC005318 | ![]() |
0.319 | D03HYX | ![]() |
0.245 | ||
| ENC002577 | ![]() |
0.313 | D0IT2G | ![]() |
0.245 | ||
| ENC003282 | ![]() |
0.309 | D0CW1P | ![]() |
0.245 | ||
| ENC002849 | ![]() |
0.301 | D07DVK | ![]() |
0.245 | ||